<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05795127</url>
  </required_header>
  <id_info>
    <org_study_id>HUS/206/2022</org_study_id>
    <nct_id>NCT05795127</nct_id>
  </id_info>
  <brief_title>Risk for Reoperation After First MTP Joint Arthrodesis</brief_title>
  <official_title>Risk for Reoperation After First MTP Joint Arthrodesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital District of Helsinki and Uusimaa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital District of Helsinki and Uusimaa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will screen all first metatarsophalangeal joint arthrodeses performed between 2010 and&#xD;
      2022 in Helsinki University Hospital. Information about demographics and additional diagnoses&#xD;
      will be yielded from data pool of medical records. Additionally we review pre- and&#xD;
      post-operative x-rays for first MTP joint angles and OR records for operative techniques.&#xD;
&#xD;
      Our aim is to find associations between those known variables and risk for reoperation in two&#xD;
      years after operation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The number of primary surgery in the adult population (age 18 years or older) will be&#xD;
      collected from patient information systems using the NOMESCO procedure code NHG80 regardless&#xD;
      of diagnosis. These patients will be further screened for diabetes and arthritic diseases&#xD;
      (the International Classification of Diseases 10th Revision (ICD-10) diagnostic codes&#xD;
      E10.**-E14.** and M05.**-M14.**). As reoperations will be considered surgery under the&#xD;
      NOMESCO procedure codes NH***, QDB***, QDG***, ZZH***. Comorbidities were collected from the&#xD;
      previous patient health records by diagnosis codes for diabetes type 1 (E10.**), other&#xD;
      diabetes (E11.**-14.**), seropositive rheumatoid arthritis (M05.9), seronegative rheumatoid&#xD;
      arthritis (M06.0), psoriasis (M07.**), gout (M10.**), other arthritis (M09.**, M11-M14).&#xD;
&#xD;
      The data will be divided and analyzed in two separate phases. First we will gather all the&#xD;
      information that we can reliably utilize from the register. The data will include the primary&#xD;
      operation, all reoperations, experience level of the surgeon, patients' age, sex, and whether&#xD;
      the patient has been diagnosed with other comorbidities stated above.&#xD;
&#xD;
      In the second phase, we will collect matched patients for the patients who underwent&#xD;
      reoperations using propensity score matching with ratio of 1:3 with nearest neighbour method.&#xD;
      The variables used for matching will be age, sex and all other comorbidities (diabetes type&#xD;
      1, other diabetes, seropositive rheumatoid arthritis, seronegative rheumatoid arthritis,&#xD;
      psoriasis, gout, other arthritis) We will further screen the medical records of the&#xD;
      reoperated patients as well the matched controls. From pre- and post-operative x-rays we will&#xD;
      determine the degree of arthrosis and hallux valgus and intermetatarsal angles. Operation&#xD;
      reports will be screened for surgical technique (i.e. method of cartilage removal, fixation&#xD;
      and use of bone transport). These data will be used to analyze the association of&#xD;
      perioperative factors and reoperations. These models will not be including variables that&#xD;
      were used in matching.&#xD;
&#xD;
      During the both phases, we will use logistic regression to analyze association between&#xD;
      assumed risk factors and reoperations by using the data from the register (first phase) or&#xD;
      from the patients' health records and x-rays (second phase). We will evaluate causality with&#xD;
      directed acyclic graphs (DAG), and develop logistic models separately for each of the assumed&#xD;
      risk factors. The variables used in the DAGs will be selected based on previous knowledge and&#xD;
      hypothesized causal relationships. Results from both analyses will interpreted with adjusted&#xD;
      odds ratios (OR) with 95 % confidence intervals (CI). Model fit will be assessed by McFadden&#xD;
      R2 -index, multicollinearity by evaluating Variance Inflation Factor (VIF) and&#xD;
      heteroscedasticity by inspecting the fitted values vs. residual plots. Statistical analyses&#xD;
      will be performed with R version 4.0.5.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2022</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reoperation</measure>
    <time_frame>2 years</time_frame>
    <description>Any OR located reoperation</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1213</enrollment>
  <condition>Hallux Rigidus</condition>
  <condition>Orthopedic Disorder</condition>
  <condition>Surgery</condition>
  <condition>Complication of Surgical Procedure</condition>
  <condition>Hallux Valgus</condition>
  <arm_group>
    <arm_group_label>Reoperated</arm_group_label>
    <description>Primary arthrodesis operations later requiring reoperation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Primary arthrodesis operations with no further operations. Size of the control group is four fold.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>First metatarsophalangeal joint arthrodesis</intervention_name>
    <description>Surgery leadin to bony uninon in firts metatarsophalangeal joint</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Reoperated</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated in Helsinki University Hospital in 2010-2022&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        First MTPJ arthrodesis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029 HUS</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 21, 2023</study_first_submitted>
  <study_first_submitted_qc>March 21, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2023</study_first_posted>
  <last_update_submitted>March 21, 2023</last_update_submitted>
  <last_update_submitted_qc>March 21, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital District of Helsinki and Uusimaa</investigator_affiliation>
    <investigator_full_name>Mikko Miettinen</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>metatarsal</keyword>
  <keyword>Hallux rigidus</keyword>
  <keyword>Hallux valgus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hallux Valgus</mesh_term>
    <mesh_term>Musculoskeletal Diseases</mesh_term>
    <mesh_term>Hallux Rigidus</mesh_term>
    <mesh_term>Hallux Limitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

